JSJairo Sanchez-Blanco

Jairo Sanchez-Blanco

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jairo Sanchez-Blanco has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Early Intervention Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: An Evidence-Based Update

    by Jairo Sánchez-Blanco, Luz Clemencia Zárate-Correa, Sébastien Hecht, Philippe Pibarot

    Degenerative aortic stenosis (AS) is the most common valvular heart disease in developed countries, particularly in individuals over 65 years of age. While the indication for aortic valve replacement in the presence of symptoms is well established, the optimal management of patients with severe asymptomatic AS remains controversial. This review integrates the epidemiology and pathophysiology of AS, the contribution of echocardiography and other diagnostic modalities (computed tomography, cardiac magnetic resonance, biomarkers), and summarizes contemporary evidence comparing early intervention versus clinical surveillance. Advanced parameters such as global longitudinal strain, mechanical dispersion, myocardial work, Global work index, as well as structural and functional cardiac damage staging systems, are highlighted. Collectively, randomized controlled trials from RECOVERY, AVATAR, EVOLVED, and EARLY transcatheter aortic valve replacement trials, complemented by registries such as CURRENT AS and observational analyses suggest that early intervention strategy reduces the risk of heart failure-related hospitalizations and cerebrovascular events in asymptomatic severe AS, while the impact on all-cause mortality remains less consistent across studies. Identifying the optimal time window for intervention before irreversible myocardial damage occurs, and refining patient selection using advanced imaging modalities, remain key priorities for both clinical practice and research. Current evidence indicates that, although watchful waiting continues to be appropriate in carefully selected patients, early intervention is gaining stronger support, particularly in those with adverse prognostic markers or in settings where close surveillance is not feasible.


  • Open Access

    A Hybrid Approach in Treating a Mycotic Aneurism Caused by MRSA: A Case Report

    by Camilo Andres Calderon-Miranda, Luz Clemencia Zárate-Correa, María Juliana Reyes-Cardona, Pastor Olaya, Jairo Sanchez-Blanco, Jorge Alexander Zambrano-Franco, Juan Pablo Carbonell, Enrique Carlos García-Pretelt, Carlos Enrique Vesga-Reyes

    BACKGROUND Mycotic aortic aneurysms (MAA) are rare but life-threatening infections of the arterial wall, characterized by rapid progression, a high risk of rupture, and poor outcomes. They most frequently occur in immunocompromised or chronically ill patients, including those with diabetes, renal failure, or on long-term hemodialysis. Early diagnosis and prompt multidisciplinary management are critical for improving survival. CASE REPORT We present the case of a 58-year-old woman with end-stage renal disease on hemodialysis via arteriovenous fistula, who was admitted with fever, gastrointestinal symptoms, and respiratory distress. Blood and pleural fluid cultures isolated methicillin-resistant Staphylococcus aureus (MRSA). Transesophageal echocardiography (TEE) and computed tomography angiography (CTA) identified a saccular aneurysm of the descending thoracic aorta, consistent with a mycotic aneurysm. Given the severity of the infection and the patient's hemodynamic instability, a hybrid approach was chosen, involving endovascular aneurysm repair (EVAR) followed by open thoracotomy for pleural debridement and empyema drainage. Despite targeted antibiotic therapy and surgical intervention, the patient developed massive intraoperative hemorrhage and refractory septic shock, ultimately resulting in death 4 days postoperatively. Intraoperative cultures of the aortic wall confirmed MRSA infection. CONCLUSIONS MAA is a diagnostic and therapeutic challenge with high morbidity and mortality, particularly in high-risk populations. Imaging modalities such as CTA and TEE are essential for early diagnosis. Management typically involves prolonged intravenous antibiotics and either surgical, endovascular, or hybrid repair. Despite aggressive treatment, the prognosis is poor, underscoring the need for further research to guide optimal treatment strategies and improve outcomes.


  • Open Access

    Percutaneous Closure of an Ischemic Ventricular Septal Rupture in a 73-Year-Old Man: A Case Report

    by Carlos Andres Mejia-Gomez, Paula Andrea Cardenas Marin, Maria Juliana Reyes-Cardona, Miller Giraldo-Sandoval, Camilo Andres Calderon-Miranda, Jorge Alexander Zambrano-Franco, Pastor Olaya, Jairo Sanchez-Blanco, Carlos Enrique Vesga-Reyes

    BACKGROUND Acquired ventricular septal defect is an uncommon complication of myocardial infarction that can require surgical repair. Percutaneous closure techniques avoid the risks associated with major cardiac surgery, particularly in elderly patients. This report presents the case of a 73-year-old man with a post-infarction ventricular septal defect successfully treated by percutaneous closure. CASE REPORT A 73-year-old man was admitted with ST-elevation myocardial infarction. Coronary angiography revealed 2-vessel disease, and successful stenting of the left anterior descending artery was performed. Transthoracic echocardiography demonstrated an apical ventricular septal defect. Given the patient's hemodynamic stability, the heart team recommended delayed percutaneous closure. However, the patient requested voluntary discharge. He was readmitted 2 weeks later with dyspnea and chest pain. The defect was closed percutaneously due to technical feasibility, elevated surgical risk, and patient preference. Post-procedural recovery was uneventful, and he was in NYHA functional class I at outpatient follow-up. CONCLUSIONS Ischemic ventricular septal rupture is a rare but potentially fatal complication of transmural myocardial infarction, requiring prompt recognition and management by a heart team. Presentation ranges from chest pain or a new murmur to cardiogenic shock. Diagnosis relies on imaging modalities, including transthoracic or transesophageal echocardiography and cardiac magnetic resonance imaging. Management options include surgical and percutaneous closure, with ventricular septal rupture repair mortality exceeding 40%. Treatment selection depends on the patient's clinical status and the size, location, and complexity of the defect. This report highlights the role of percutaneous closure in post-infarction ventricular septal rupture and illustrates a successful outcome in an elderly patient.

  • Open Access

    Postpartum ischemic stroke due to persistent left superior vena cava to left atrium after DORV repair: a case report and literature review

    by Paula Andrea Cárdenas-Marín, Jorge Alexander Zambrano-Franco, Maria Juliana Reyes-Cardona, Camilo Andres Calderon-Miranda, Jairo Sanchez-Blanco, Pastor Olaya, Carlos Enrique Vesga-Reyes

    Background: Persistent left superior vena cava (PLSVC) is the most common thoracic venous anomaly and is often associated with complex congenital heart disease (CHD). Venous drainage typically occurs into the right atrium via the coronary sinus (CS). However, in 10–20% of cases, it drains into the left atrium, producing a right-to-left shunt that may result in symptoms and cerebrovascular complications. Case presentation: A 23-year-old woman with a history of double-outlet right ventricle corrected at age 13 presented in the postpartum period with dysarthria, left central facial palsy and left hemiparesis. Brain MRI angiography revealed right middle cerebral artery (M2) occlusion, and she underwent thrombolysis and thrombectomy. Suspecting a cardioembolic event, transesophageal echocardiography with left-arm agitated saline injection revealed early left atrial opacification and delayed right-sided filling via a residual ventricular septal defect —suggesting a PLSVC draining into the left atrium. Cardiac CT confirmed CS agenesis and a PLSVC connected to the left atrial roof. She was discharged on enoxaparin. Conclusions: PLSVC is a vascular anomaly with an estimated prevalence of 0.2-3% in the general population and 1-12% among CHD patients. A dilated CS on transthoracic echocardiography should prompt a bubble test; early opacification of the left chambers after left-arm saline injection suggests drainage to the left atrium. Cardiac CT, MRI or invasive angiography can clarify the anatomy. PLSVC has clinical implications including technical considerations for percutaneous procedures and cardiac surgery, a predisposition for arrhythmias, and —when draining into the left atrium— an increased risk of cerebrovascular events. Closure of a PLSVC draining into the left atrium should be considered in symptomatic patients or those at high risk of paradoxical embolism, following anatomical assessment. In pregnant women with CHD, cardiac risk assessment, multimodal imaging and multidisciplinary follow-up are crucial due to associated hemodynamic changes and hypercoagulable state.